Efficacy of intradialytic amino acids on nutritional status in children with stage 5 chronic kidney disease
Authors:
- Hagar El-Saied Saad El-SerwHEHagar El-Saied Saad El-Serw
- Dina Abdel Rasoul Helal BassiouniDBDina Abdel Rasoul Helal Bassiouni
- Angy Adel Al-WakeilAAAngy Adel Al-Wakeil
- Ragaa Shawky Aly Ibrahim El-MasryRERagaa Shawky Aly Ibrahim El-Masry
- Ashraf Mohamed Abd Ei Basset BakrABAshraf Mohamed Abd Ei Basset Bakr
- 18 November 2020
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 36 (6) , 1561-1569
Abstract
Background Protein energy wasting (PEW) is a common cause of morbidity and mortality in patients with stage 5 chronic kidney disease (CKD 5). Intradialytic parenteral nutrition (IDPN) has been used as a therapy for preventing and treating PEW in children with CKD 5 when other conventional modalities fail. However, not enough data is available to define its effectiveness in treating malnutrition in children. This study aims to investigate potential benefits of IDPN in Egyptian children with CKD 5. Methods In this prospective, placebo-controlled, parallel-group single blinded study, we enrolled 50 CKD 5 patients; 25 patients (intervention group) received intravenous amino acids (KIDIMN), while 25 patients (control group) received normal saline as placebo, each given during regular dialysis 3 times a week for 9 months. Patients were subjected to nutritional assessment at baseline and 3-, 6-, and 9-month follow-up using height Z-score, hand grip strength (HGS) for muscle power assessment, body composition monitor (BCM) for assessing lean tissue mass (LTM) and adipose tissue mass (ATM), and biochemical measures including serum albumin, serum triglyceride, and serum cholesterol. Results When comparing baseline and 9-month follow-up values, significant improvement was recorded in height Z-score, LTM, and serum albumin in the intervention group unlike the control group where no significant changes were recorded. Conclusion IDPN is proposed to be an effective method for preventing and treating malnutrition in children with CKD 5. However, further multi-centric studies with larger sample size and longer duration of follow-up are still recommended.Keywords
This publication has 26 references indexed in Scilit:
- Why cachexia kills: examining the causality of poor outcomes in wasting conditionsJournal of Cachexia, Sarcopenia and Muscle, 2013
- Etiology of the Protein-Energy Wasting Syndrome in Chronic Kidney Disease: A Consensus Statement From the International Society of Renal Nutrition and Metabolism (ISRNM)Journal of Renal Nutrition, 2013
- Growth in Very Young Children Undergoing Chronic Peritoneal DialysisJournal of the American Society of Nephrology, 2011
- A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approachAge and Ageing, 2011
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010
- ESPEN Guidelines on Parenteral Nutrition: Adult Renal FailureClinical Nutrition, 2009
- A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney diseaseKidney International, 2008
- Intradialytic Parenteral Nutrition Does Not Improve Survival in Malnourished Hemodialysis PatientsJournal of the American Society of Nephrology, 2007
- Effect of intradialytic parenteral nutrition in patients with malnutrition–inflammation complex syndrome on body weight, inflammation, serum lipids and adipocytokines: results from a pilot studyEuropean Journal of Clinical Nutrition, 2007
- Hypoalbuminemia and risk of death in pediatric patients with end-stage renal diseaseKidney International, 2002